Skip to main content

Client News

Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval

13th September 2023

Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 81%

13th September 2023

InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904

11th September 2023

Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update

8th September 2023

Abivax provides business and operational update

7th September 2023

AdhereTech Appoints Innes Meldrum as President and Chief Executive Officer

6th September 2023

Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library with the full chemistry support of Enamine

6th September 2023

Element Materials unveils fully integrated pharma services platform, strengthening its expanding Life Sciences Division

5th September 2023

invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding

5th September 2023

Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market

5th September 2023